Cargando…
Comparison of short‐term outcomes following minimally invasive versus open Sweet esophagectomy for Siewert type II adenocarcinoma of the esophagogastric junction
BACKGROUND: Surgical resection is still the main treatment option for patients with resectable Siewert type II adenocarcinoma of the esophagogastric junction (AEG). This retrospective study evaluated the significance of minimally invasive Sweet esophagectomy (MISE) for the treatment of Siewert type...
Autores principales: | Sun, Xiaohui, Wang, Gaoxiang, Liu, Changqing, Xiong, Ran, Wu, Hanran, Xie, Mingran, Xu, Shibin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262901/ https://www.ncbi.nlm.nih.gov/pubmed/32239662 http://dx.doi.org/10.1111/1759-7714.13415 |
Ejemplares similares
-
Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: Erratum
Publicado: (2017) -
The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients
por: Goto, Hironobu, et al.
Publicado: (2014) -
Feasibility and efficacy of transthoracic single-port assisted laparoscopic esophagogastrectomy for Siewert type II adenocarcinoma of the esophagogastric junction
por: Luo, Sijing, et al.
Publicado: (2021) -
Laparoscopic-assisted vs open transhiatal gastrectomy for Siewert type II adenocarcinoma of the esophagogastric junction: A retrospective cohort study
por: Song, Qi-Ying, et al.
Publicado: (2022) -
Clinical application and observation of modified Ivor-Lewis surgery in Siewert type II adenocarcinoma of the Esophagogastric junction
por: Yin, Qifan, et al.
Publicado: (2019)